Table 3 Comparison of diagnostic performance of CT attenuation-based parameters for assessing hepatic steatosis between patients with and without severe fibrosis.
Hepatic steatosis grades | CT parameters | AUROC (95% CI) | P-value* | |
---|---|---|---|---|
Patients with severe fibrosis (n = 70) | Patients without severe fibrosis (n = 173) | |||
Mild | L_pre | 0.645 (0.521–0.756) | 0.698 (0.623–0.765) | 0.56 |
L-S_pre | 0.568 (0.444–0.686) | 0.634 (0.557–0.706) | 0.48 | |
L_post | 0.623 (0.499–0.736) | 0.694 (0.620–0.762) | 0.40 | |
L-S_post | 0.516 (0.394–0.638) | 0.642 (0.566–0.713) | 0.15 | |
Moderate | L_pre | 0.676 (0.554–0.783) | 0.804 (0.737–0.861) | 0.22 |
L-S_pre | 0.616 (0.492–0.730) | 0.707 (0.633–0.773) | 0.43 | |
L_post | 0.621 (0.497–0.734) | 0.744 (0.673–0.808) | 0.19 | |
L-S_post | 0.564 (0.440–0.682) | 0.706 (0.633–0.773) | 0.15 | |
Severe | L_pre | 0.659 (0.536–0.769) | 0.843 (0.781–0.894) | 0.13 |
L-S_pre | 0.687 (0.565–0.793) | 0.742 (0.670–0.806) | 0.66 | |
L_post | 0.706 (0.585–0.809) | 0.755 (0.684–0.817) | 0.58 | |
L-S_post | 0.525 (0.402–0.646) | 0.765 (0.695–0.826) | 0.037 |